Asian Pacific Journal of Cancer Prevention

  • 제15권15호
  • /
  • Pages.6321-6326
  • /
  • 2014
  • /
  • 1513-7368(pISSN)
  • /
  • 2476-762X(eISSN)
아시아태평양암예방학회 (Asian Pacific Journal of Cancer Prevention)
권호 표지
DOI QR코드

DOI QR Code

Activation of JNK/p38 Pathway is Responsible for α-Methyl-n-butylshikonin Induced Mitochondria-Dependent Apoptosis in SW620 Human Colorectal Cancer Cells

  • Wang, Hai-Bing (National Clinical Research Base of Traditional Chinese Medicine, Zhejiang Provincial Hospital of Traditional Chinese Medicine, Zhejiang Chinese Medical University) ;
  • Ma, Xiao-Qiong (National Clinical Research Base of Traditional Chinese Medicine, Zhejiang Provincial Hospital of Traditional Chinese Medicine, Zhejiang Chinese Medical University)
  • 발행 : 2014.08.15
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

${\alpha}$-Methyl-n-butylshikonin (MBS), one of the active components in the root extracts of Lithospermum erythrorhizon, posses antitumor activity. In this study, we assess the molecular mechanisms of MBS in causing apoptosis of SW620 cells. MBS reduced the cell viability of SW620 cells in a dose-and time-dependent manner and induced cell apoptosis. Treatment of SW620 cells with MBS down-regulated the expression of Bcl-2 and up-regulated the expression of Bak and caused the loss of mitochondrial membrane potential. Additionally, MBS treatment led to activation of caspase-9, caspase-8 and caspase-3, and cleavage of PARP, which was abolished by pretreatment with the pan-caspase inhibitor Z-VAD-FMK. MBS also induced significant elevation in the phosphorylation of JNK and p38. Pretreatment of SW620 cells with specific inhibitors of JNK (SP600125) and p38 (SB203580) abrogated MBS-induced apoptosis. Our results demonstrated that MBS inhibited growth of colorectal cancer SW620 cells by inducing JNK and p38 signaling pathway, and provided a clue for preclinical and clinical evaluation of MBS for colorectal cancer therapy.

키워드

참고문헌

  1. Andujar I, Recio MC, Giner RM, Rios JL (2013). Traditional chinese medicine remedy to jury: the pharmacological basis for the use of shikonin as an anticancer therapy. Curr Med Chem, 20, 2892-8. https://doi.org/10.2174/09298673113209990008
  2. Avisetti DR, Babu KS, Kalivendi SV (2014). Activation of p38/JNK pathway is responsible for embelin induced apoptosis in lung cancer cells: transitional role of reactive oxygen species. PLoS One, 9, 87050. https://doi.org/10.1371/journal.pone.0087050
  3. Brentnall M, Rodriguez-Menocal L, De Guevara RL, et al (2013). Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis. BMC Cell Biol, 14, 32. https://doi.org/10.1186/1471-2121-14-32
  4. Baines CP, Molkentin JD (2005). STRESS signaling pathways that modulate cardiac myocyte apoptosis. J Mol Cell Cardiol, 38, 47-62. https://doi.org/10.1016/j.yjmcc.2004.11.004
  5. Bennett BL1, Sasaki DT, Murray BW, et al (2001). SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci U S A, 98, 13681-6. https://doi.org/10.1073/pnas.251194298
  6. Chen J, Xie J, Jiang Z, et al (2011). Shikonin and its analogs inhibit cancer cell glycolysis by targeting tumor pyruvate kinase-M2. Oncogene, 30, 4297-306. https://doi.org/10.1038/onc.2011.137
  7. Chen X, Yang L, Zhang N, et al (2003). Shikonin, a component of chinese herbal medicine, inhibits chemokine receptor function and suppresses human immunodeficiency virus type 1. Antimicrob Agents Chemother, 47, 2810-6. https://doi.org/10.1128/AAC.47.9.2810-2816.2003
  8. Cory S, Adams JM (2002). The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer, 2, 647-56. https://doi.org/10.1038/nrc883
  9. Huang C, Luo Y, Zhao J, et al (2013). Shikonin kills glioma cells through necroptosis mediated by RIP-1. PLoS One, 8, 66326. https://doi.org/10.1371/journal.pone.0066326
  10. Hsu PC, Huang YT, Tsai ML, et al (2004). Induction of apoptosis by shikonin through coordinative modulation of the Bcl-2 family, p27, and p53, release of cytochrome c, and sequential activation of caspases in human colorectal carcinoma cells. J Agric Food Chem, 52, 6330-7. https://doi.org/10.1021/jf0495993
  11. Hu W, Kavanagh JJ (2003). Anticancer therapy targeting the apoptotic pathway. Lancet Oncol, 4, 721-9. https://doi.org/10.1016/S1470-2045(03)01277-4
  12. Hu F, Han J, Zhai B, et al (2014). Blocking autophagy enhances the apoptosis effect of bufalin on human hepatocellular carcinoma cells through endoplasmic reticulum stress and JNK activation. Apoptosis, 19, 210-23. https://doi.org/10.1007/s10495-013-0914-7
  13. Hsieh CJ, Kuo PL, Hsu YC, et al (2014). Arctigenin, a dietary phytoestrogen, induces apoptosis of estrogen receptornegative breast cancer cells through the ROS/p38 MAPK pathway and epigenetic regulation. Free Radic Biol Med, 67, 159-70. https://doi.org/10.1016/j.freeradbiomed.2013.10.004
  14. Igney FH, Krammer PH (2002). Death and anti-death: tumour resistance to apoptosis. Nat Rev Cancer, 2, 277-88. https://doi.org/10.1038/nrc776
  15. Ko FN, Lee YS, Kuo SC, et al (1995). Inhibition on platelet activation by shikonin derivatives isolated from Arnebia euchroma. Biochim Biophys Acta, 1268, 329-34. https://doi.org/10.1016/0167-4889(95)00078-7
  16. Kayali AG, Austin DA, Webster NJ (2000). Stimulation of MAPK cascades by insulin and osmotic shock: lack of an involvement of p38 mitogen-activated protein kinase in glucose transport in 3T3-L1 adipocytes. Diabetes, 49, 1783-93. https://doi.org/10.2337/diabetes.49.11.1783
  17. Ly JD, Grubb DR, Lawen A (2003). The mitochondrial membrane potential (deltapsi(m)) in apoptosis; an update. Apoptosis, 8, 115-28. https://doi.org/10.1023/A:1022945107762
  18. Li M, Jiang XG, Gu ZL, Zhang ZB (2013). Glaucocalyxin A activates FasL and induces apoptosis through activation of the JNK pathway in human breast cancer cells. Asian Pac J Cancer Prev, 14, 5805-10. https://doi.org/10.7314/APJCP.2013.14.10.5805
  19. Mantena SK, Sharma SD, Katiyar SK (2006). Berberine inhibits growth, induces G1 arrest and apoptosis in human epidermoid carcinoma A431 cells by regulating Cdki-Cdk-cyclin cascade, disruption of mitochondrial membrane potential and cleavage of caspase-3 and PARP. Carcinogenesis, 27, 2018-27. https://doi.org/10.1093/carcin/bgl043
  20. Ola MS, Nawaz M, Ahsan H (2011). Role of Bcl-2 family proteins and caspases in the regulation of apoptosis. Mol Cell Biochem, 351, 41-58. https://doi.org/10.1007/s11010-010-0709-x
  21. Raman M, Chen W, Cobb MH (2007). Differential regulation and properties of MAPKs. Oncogene, 26, 3100-12. https://doi.org/10.1038/sj.onc.1210392
  22. Siegel R, Naishadham D, Jemal A (2013). Cancer statistics. CA Cancer J Clin, 63, 11-30. https://doi.org/10.3322/caac.21166
  23. Shen CC, Syu WJ, Li SY, et al (2002). Antimicrobial activities of naphthazarins from Arnebia euchroma. J Nat Prod, 65, 1857-62. https://doi.org/10.1021/np010599w
  24. Shen XJ, Wang HB, Ma XQ, Chen JH (2012). $\beta$,$\beta$-Dimethylacrylshikonin induces mitochondria dependent apoptosis through ERK pathway in human gastric cancer SGC-7901 cells. PLoS One, 7, 41773. https://doi.org/10.1371/journal.pone.0041773
  25. Shimizu S, Narita M, Tsujimoto Y (1999). Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature, 399, 483-7. https://doi.org/10.1038/20959
  26. Tanaka S, Tajima M, Tsukada M, Tabata M (1986). A comparative study on anti-inflammatory activities of the enantiomers, shikonin and alkannin. J Nat Prod, 49, 466-9. https://doi.org/10.1021/np50045a014
  27. Tournier C, Hess P, Yang DD, et al (2000). Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science, 288, 870-4. https://doi.org/10.1126/science.288.5467.870
  28. Tait SW, Green DR (2010). Mitochondria and cell death: outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol , 11, 621-32. https://doi.org/10.1038/nrm2952
  29. Wang R, Yin R, Zhou W, et al (2012). Shikonin and its derivatives: a patent review. Expert Opin Ther Pat, 22, 977-97. https://doi.org/10.1517/13543776.2012.709237
  30. Wada T, Penninger JM (2004). Mitogen-activated protein kinases in apoptosis regulation. Oncogene, 23, 2838-49. https://doi.org/10.1038/sj.onc.1207556
  31. Xia Z, Dickens M, Raingeaud J, (1995). Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science, 270, 1326-31. https://doi.org/10.1126/science.270.5240.1326
  32. Xuan Y, Hu X (2009). Naturally-occurring shikonin analogues-a class of necroptotic inducers that circumvent cancer drug resistance. Cancer Lett, 274, 233-42. https://doi.org/10.1016/j.canlet.2008.09.029
  33. Zeng Y, Liu G, Zhou LM (2009). Inhibitory effect of acetylshikonin on human gastric carcinoma cell line SGC-7901 in vitro and in vivo. World J Gastroenterol, 15, 1816-20. https://doi.org/10.3748/wjg.15.1816